Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
Delsing DJ, Offerman EH, van Duyvenvoorde W, van Der Boom H, de Wit EC, Gijbels MJ, van Der Laarse A, Jukema JW, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: van duyvenvoorde w, van der laarse a, van der boom h. Circulation. 2001 Apr 3;103(13):1778-86. doi: 10.1161/01.cir.103.13.1778. Circulation. 2001. PMID: 11282910
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Trion A, de Maat MP, Jukema JW, van der Laarse A, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HM, Emeis JJ. Trion A, et al. Among authors: van der laarse a. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1635-40. doi: 10.1161/01.ATV.0000171992.36710.1e. Epub 2005 May 26. Arterioscler Thromb Vasc Biol. 2005. PMID: 15920036
Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
Zhao SP, Smelt AH, Van den Maagdenberg AM, Van Tol A, Vroom TF, Gevers Leuven JA, Frants RR, Havekes LM, Van der Laarse A, Van 't Hooft FM. Zhao SP, et al. Among authors: van t hooft fm, van den maagdenberg am, van tol a, van der laarse a. Arterioscler Thromb. 1994 Nov;14(11):1705-16. doi: 10.1161/01.atv.14.11.1705. Arterioscler Thromb. 1994. PMID: 7947593
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.
Jukema JW, Zwinderman AH, van Boven AJ, Reiber JH, Van der Laarse A, Lie KI, Bruschke AV. Jukema JW, et al. Among authors: van der laarse a, van boven aj. Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):425-30. doi: 10.1161/01.atv.16.3.425. Arterioscler Thromb Vasc Biol. 1996. PMID: 8630669 Clinical Trial.
Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients.
Hau MF, Smelt AH, Bindels AJ, Sijbrands EJ, Van der Laarse A, Onkenhout W, van Duyvenvoorde W, Princen HM. Hau MF, et al. Among authors: van duyvenvoorde w, van der laarse a. Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1197-202. doi: 10.1161/01.atv.16.9.1197. Arterioscler Thromb Vasc Biol. 1996. PMID: 8792775
319 results